Features of clinical and sonographic symptoms in chronic pancreatitis with ischemic heart disease

D. Hontsariuk, K. Ferfetska, L. Pits, A. Kravchuk
{"title":"Features of clinical and sonographic symptoms in chronic pancreatitis with ischemic heart disease","authors":"D. Hontsariuk, K. Ferfetska, L. Pits, A. Kravchuk","doi":"10.24061/2413-0737.xxvi.2.102.2022.2","DOIUrl":null,"url":null,"abstract":"Aim of the study. To investigate the features of the clinical course of chronic pancreatitis in comorbidity with ischemic heart disease.Research methods. We used a survey, anamnesis, objective examination, biochemical, radioimmune (indicators of insulin in the blood), instrumental (sonographic, ECG), statistical (computer analysis of data). The criteria for inclusion in chronic pancreatitis were exacerbations, abdominal pain and dyspeptic syndrome, sonographic changes in the pancreas, risk factors, patient consent for the study. The criteria for inclusion in ischemic heart disease were stable exertional angina FC I-II, CHF IIA-B, FC II-III (NYHA) in the absence of angina attacks within 3 months; regular treatment for 3 months, patient's consent. The exclusion criteria included oncological diseases, acute exacerbations of CP, myocardial infarction in the last 3 months, chronic kidney disease, and diabetes mellitus. The study was carried out in accordance with the Order of the Ministry of Health of Ukraine No.281 dated 1.11.2000. The study guidance and informed consent form were approved by the Commission on Biomedical Ethics of Bukovina State Medical University.Results. The aggravating nature of the course of the disease, the polymorphism of clinical symptoms, especially the pain syndrome, which did not always have a clear localization, irradiation, intensity and was absent in about 15%, was established. The atypical course in 83.3% of cases was associated with diseases of the digestive system. In 70.0% of patients, atherosclerotic changes in the vessels of the abdominal cavity were revealed, in 47.5% of them, lesions of the carotid artery at the stage of atheromatous plaque or its atherothrombosis, stenosis of the vascular lumen and hemodynamic disturbances were diagnosed. There was a tendency to a decrease in the ejection fraction, cardiac and stroke volumes against the background of an increase in the end systolic volume (ESV), end diastolic volume (EDV) with an EF of 50.4 ± 2.3%.Conclusion. The clinical course of chronic pancreatitis in comorbidity with ischemic heart disease is characterized by prolonged formation (more than 10 years), accompanied by structural and morphological changes in the pancreas of a fibrosing nature, the presence of atherosclerotic changes in the carotid arteries, atherosclerotic lesions of the aorta, mesenteric dysfunction, diastolic course, the possibility of premature fatal cardiovascular problems and the association with concomitant gastroenterological diseases.","PeriodicalId":9270,"journal":{"name":"Bukovinian Medical Herald","volume":"37 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bukovinian Medical Herald","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24061/2413-0737.xxvi.2.102.2022.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim of the study. To investigate the features of the clinical course of chronic pancreatitis in comorbidity with ischemic heart disease.Research methods. We used a survey, anamnesis, objective examination, biochemical, radioimmune (indicators of insulin in the blood), instrumental (sonographic, ECG), statistical (computer analysis of data). The criteria for inclusion in chronic pancreatitis were exacerbations, abdominal pain and dyspeptic syndrome, sonographic changes in the pancreas, risk factors, patient consent for the study. The criteria for inclusion in ischemic heart disease were stable exertional angina FC I-II, CHF IIA-B, FC II-III (NYHA) in the absence of angina attacks within 3 months; regular treatment for 3 months, patient's consent. The exclusion criteria included oncological diseases, acute exacerbations of CP, myocardial infarction in the last 3 months, chronic kidney disease, and diabetes mellitus. The study was carried out in accordance with the Order of the Ministry of Health of Ukraine No.281 dated 1.11.2000. The study guidance and informed consent form were approved by the Commission on Biomedical Ethics of Bukovina State Medical University.Results. The aggravating nature of the course of the disease, the polymorphism of clinical symptoms, especially the pain syndrome, which did not always have a clear localization, irradiation, intensity and was absent in about 15%, was established. The atypical course in 83.3% of cases was associated with diseases of the digestive system. In 70.0% of patients, atherosclerotic changes in the vessels of the abdominal cavity were revealed, in 47.5% of them, lesions of the carotid artery at the stage of atheromatous plaque or its atherothrombosis, stenosis of the vascular lumen and hemodynamic disturbances were diagnosed. There was a tendency to a decrease in the ejection fraction, cardiac and stroke volumes against the background of an increase in the end systolic volume (ESV), end diastolic volume (EDV) with an EF of 50.4 ± 2.3%.Conclusion. The clinical course of chronic pancreatitis in comorbidity with ischemic heart disease is characterized by prolonged formation (more than 10 years), accompanied by structural and morphological changes in the pancreas of a fibrosing nature, the presence of atherosclerotic changes in the carotid arteries, atherosclerotic lesions of the aorta, mesenteric dysfunction, diastolic course, the possibility of premature fatal cardiovascular problems and the association with concomitant gastroenterological diseases.
慢性胰腺炎合并缺血性心脏病的临床和声像图特征
研究的目的。探讨慢性胰腺炎合并缺血性心脏病的临床病程特点。研究方法。我们采用调查、记忆、客观检查、生化、放射免疫(血液中胰岛素指标)、仪器(超声、心电图)、统计学(数据计算机分析)。纳入慢性胰腺炎的标准是病情加重、腹痛和消化不良综合征、胰腺超声改变、危险因素、患者同意研究。纳入缺血性心脏病的标准是3个月内无心绞痛发作的稳定劳损性心绞痛FC - I-II、CHF IIA-B、FC II-III (NYHA);定期治疗3个月,经患者同意。排除标准包括肿瘤疾病、CP急性加重、近3个月心肌梗死、慢性肾病和糖尿病。这项研究是根据乌克兰卫生部2000年11月1日第281号命令进行的。研究指南和知情同意书经布科维纳州立医科大学生物医学伦理委员会批准。确立了疾病病程的加重性,临床症状的多态性,尤其是疼痛综合征,其并不总是有明确的定位、照射、强度,约15%的疼痛综合征不存在。83.3%的非典型病程与消化系统疾病有关。70.0%的患者发现腹腔血管出现动脉粥样硬化改变,其中47.5%的患者诊断为动脉粥样硬化斑块或其动脉粥样血栓形成阶段的颈动脉病变、血管腔狭窄和血流动力学紊乱。射血分数、心脏和脑卒中容量有降低的趋势,而收缩期末容积(ESV)和舒张期末容积(EDV)增加,EF为50.4±2.3%。慢性胰腺炎合并缺血性心脏病的临床病程特点是形成时间较长(超过10年),伴有胰腺纤维化性质的结构和形态改变,颈动脉存在动脉粥样硬化改变,主动脉动脉粥样硬化病变,肠系膜功能障碍,舒张过程,过早致死性心血管疾病的可能性及其与伴随的胃肠疾病的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信